StockData
Genprex, Inc. logo

Genprex, Inc. (GNPX) stock

GNPXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.90−0.18 (-8.65%)

Close on Nov 16, 2026Market cap $1.56MP/E –Yield –

Genprex r&d expenses

Research and development expenses are spending on new products and technology.

Genprex's R&D Expenses for the twelve months ending Jun 30, 2026 was $9.82M, down 7.7% year over year. For fiscal 2025 it was $9.43M, down 10.5% from the year before. The highest annual figure on record is $17.62M in fiscal 2023.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$9.43M-10.5%
FY2024Dec 31, 2024$10.54M-40.2%
FY2023Dec 31, 2023$17.62M+53.1%
FY2022Dec 31, 2022$11.51M+28.3%
FY2021Dec 31, 2021$8.97M+22.8%
FY2020Dec 31, 2020$7.30M+271.3%
FY2019Dec 31, 2019$1.97M+102.5%
FY2018Dec 31, 2018$971.43K+235.1%
FY2017Dec 31, 2017$289.93K-18.3%
FY2016Dec 31, 2016$354.88K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.68M+7.4%
Q1 FY2026Mar 31, 2026$2.75M+8.1%
Q4 FY2025Dec 31, 2025$2.20M-22.6%
Q3 FY2025Sep 30, 2025$2.19M-20.4%
Q2 FY2025Jun 30, 2025$2.50M+50.0%
Q1 FY2025Mar 31, 2025$2.54M-22.4%
Q4 FY2024Dec 31, 2024$2.84M-23.6%
Q3 FY2024Sep 30, 2024$2.76M-40.3%
Q2 FY2024Jun 30, 2024$1.67M-58.1%
Q1 FY2024Mar 31, 2024$3.27M-38.3%
Q4 FY2023Dec 31, 2023$3.71M+9.7%
Q3 FY2023Sep 30, 2023$4.62M+46.2%
Q2 FY2023Jun 30, 2023$3.98M+35.9%
Q1 FY2023Mar 31, 2023$5.31M+160.3%
Q4 FY2022Dec 31, 2022$3.39M-11.9%
Q3 FY2022Sep 30, 2022$3.16M+120.5%
Q2 FY2022Jun 30, 2022$2.93M+91.8%
Q1 FY2022Mar 31, 2022$2.04M-0.0%
Q4 FY2021Dec 31, 2021$3.84M+65.7%
Q3 FY2021Sep 30, 2021$1.43M+6.1%
Q2 FY2021Jun 30, 2021$1.53M-29.2%
Q1 FY2021Mar 31, 2021$2.04M+38.1%
Q4 FY2020Dec 31, 2020$2.32M+373.8%
Q3 FY2020Sep 30, 2020$1.35M+188.9%
Q2 FY2020Jun 30, 2020$2.16M+329.4%
Q1 FY2020Mar 31, 2020$1.48M+190.9%
Q4 FY2019Dec 31, 2019$489.58K+54.4%
Q3 FY2019Sep 30, 2019$467.34K-4.6%
Q2 FY2019Jun 30, 2019$502.04K+344.4%
Q1 FY2019Mar 31, 2019$508.04K+884.2%
Q4 FY2018Dec 31, 2018$317.15K+419.3%
Q3 FY2018Sep 30, 2018$489.69K+782.1%
Q2 FY2018Jun 30, 2018$112.97K+7.6%
Q1 FY2018Mar 31, 2018$51.62K-24.5%
Q4 FY2017Dec 31, 2017$61.07K-52.8%
Q3 FY2017Sep 30, 2017$55.52K-38.2%
Q2 FY2017Jun 30, 2017$104.98K–
Q1 FY2017Mar 31, 2017$68.36K–
Q4 FY2016Dec 31, 2016$129.34K–
Q3 FY2016Sep 30, 2016$89.90K–

More Genprex figures

See a number that looks wrong?